Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08DBE
|
|||
Former ID |
DIB007896
|
|||
Drug Name |
R-343
|
|||
Synonyms |
R-921303; Syk tyrosine kinase inhibitor (allergic asthma), Rigel/Pfizer
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Discontinued in Phase 2 | [1] | |
Company |
Rigel Pharmaceuticals Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H17F3N6O4
|
|||
Canonical SMILES |
CNC(=O)COC1=CC=CC(=C1)NC2=NC=C(C(=N2)NC3=CC4=C(C=C3)OC(C(=O)N4)(F)F)F
|
|||
InChI |
1S/C21H17F3N6O4/c1-25-17(31)10-33-13-4-2-3-11(7-13)28-20-26-9-14(22)18(30-20)27-12-5-6-16-15(8-12)29-19(32)21(23,24)34-16/h2-9H,10H2,1H3,(H,25,31)(H,29,32)(H2,26,27,28,30)
|
|||
InChIKey |
MOXXQFNQDDSJHT-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027577) | |||
REF 2 | A novel Syk kinase inhibitor suitable for inhalation: R-343(. Expert Opin Ther Pat. 2009 Oct;19(10):1469-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.